scholarly journals Methyl-CpG-binding protein 2(MECP2) mutation type is associated with disease severity in Rett syndrome

2014 ◽  
Vol 51 (3) ◽  
pp. 152-158 ◽  
Author(s):  
Vishnu Anand Cuddapah ◽  
Rajesh B Pillai ◽  
Kiran V Shekar ◽  
Jane B Lane ◽  
Kathleen J Motil ◽  
...  
2019 ◽  
Author(s):  
Carla Caffarelli ◽  
Tomai Pitinca Maria Dea ◽  
Valentina Francolini ◽  
Roberto Canitano ◽  
felice Claudio De ◽  
...  

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Carla Caffarelli ◽  
Stefano Gonnelli ◽  
Maria Dea Tomai Pitinca ◽  
Silvia Camarri ◽  
Antonella Al Refaie ◽  
...  

2008 ◽  
Vol 23 (10) ◽  
pp. 1384-1390 ◽  
Author(s):  
Teresa Temudo ◽  
Elisabete Ramos ◽  
Karin Dias ◽  
Clara Barbot ◽  
Jose P. Vieira ◽  
...  

2011 ◽  
Vol 5 (1) ◽  
pp. 442-449 ◽  
Author(s):  
Deidra Young ◽  
Ami Bebbington ◽  
Nick de Klerk ◽  
Carol Bower ◽  
Lakshmi Nagarajan ◽  
...  

2018 ◽  
Vol 40 (10) ◽  
pp. 943-946 ◽  
Author(s):  
Hiroo Tani ◽  
Nobutsune Ishikawa ◽  
Yoshiyuki Kobayashi ◽  
Shohei Yamaoka ◽  
Yuji Fujii ◽  
...  

2019 ◽  
Vol 6 (1) ◽  
Author(s):  
Eri Takeshita ◽  
Aritoshi Iida ◽  
Chihiro Abe-Hatano ◽  
Eiji Nakagawa ◽  
Masayuki Sasaki ◽  
...  

Abstract Rett syndrome (RTT) is an X-linked progressive and severe neurological disorder caused by mutations in the gene encoding methyl CpG binding protein 2 (MECP2). Among the 49 typical RTT patients examined, we identified 10 novel and eight known insertion/deletion variants, and 31 known pathogenic variants in MECP2. The pathogenic variants presented here should be a useful resource for examining the correlation between the genotypes and phenotypes of RTT.


Sign in / Sign up

Export Citation Format

Share Document